Literature DB >> 26944318

MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.

Jing-Song Chen1, Hua-Shu Li2, Jiong-Qiang Huang1, Shi-Hao Dong1, Zhi-Jie Huang1, Wei Yi1, Gao-Fang Zhan1, Ju-Tao Feng1, Jian-Cong Sun1, Xiao-Hui Huang3.   

Abstract

Some microRNAs (miRNAs) have been implicated in hepatocellular carcinoma (HCC) development and progression. However, the roles and mechanisms of several miRNAs in HCC remain poorly understood. Here, we report that miR-379-5p, which is down-regulated in HCC tissues and cell lines, is associated with advanced TNM stage and metastasis in HCC. The ectopic overexpression of miR-379-5p inhibited HCC cell migration, invasion, epithelial-to-mesenchymal transition (EMT) and metastasis both in vitro and in vivo. Conversely, miR-379 knockdown increased migration, invasion and EMT in HCC cells. Moreover, miR-379-5p exerted this function by directly targeting focal adhesion kinase (FAK) 3'-UTR and repressing FAK expression, thus leading to suppression of AKT signaling. Furthermore, the tumor suppressive effects of miR-379-5p in HCC cells were reversed by activating AKT signaling or restoring FAK expression. In clinical samples of HCC, miR-379-5p negatively correlated with FAK, which was up-regulated in HCC. Taken together, our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling, suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Focal adhesion kinase; Hepatocellular carcinoma; Invasion; Metastasis; miR-379-5p

Mesh:

Substances:

Year:  2016        PMID: 26944318     DOI: 10.1016/j.canlet.2016.02.043

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

1.  Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.

Authors:  K P O'Brien; S Khan; K E Gilligan; H Zafar; P Lalor; C Glynn; C O'Flatharta; H Ingoldsby; P Dockery; A De Bhulbh; J R Schweber; K St John; M Leahy; J M Murphy; W M Gallagher; T O'Brien; M J Kerin; R M Dwyer
Journal:  Oncogene       Date:  2018-01-25       Impact factor: 9.867

2.  A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.

Authors:  Xiaoyan Xu; Yumeng Wang; Kamalika Mojumdar; Zhicheng Zhou; Kang Jin Jeong; Lingegowda S Mangala; Shuangxing Yu; Yiu Huen Tsang; Cristian Rodriguez-Aguayo; Yiling Lu; Gabriel Lopez-Berestein; Anil K Sood; Gordon B Mills; Han Liang
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

3.  Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-3.

Authors:  X Xie; J Ji; X Chen; W Xu; H Chen; S Zhu; J Wu; Y Wu; Y Sun; W Sai; Z Liu; M Xiao; B Bao
Journal:  Clin Transl Oncol       Date:  2021-11-23       Impact factor: 3.405

4.  MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.

Authors:  Ke Yang; Danyang Li; Weihui Jia; Yanmei Song; Ningxin Sun; Jiemin Wang; Hongli Li; Chonggao Yin
Journal:  Thorac Cancer       Date:  2022-05-24       Impact factor: 3.223

Review 5.  Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy.

Authors:  Behnoush Sohrabi; Behnaz Dayeri; Elahe Zahedi; Shahrouz Khoshbakht; Najme Nezamabadi Pour; Hamta Ranjbar; Abolfazl Davari Nejad; Mahdi Noureddini; Behrang Alani
Journal:  Cancer Gene Ther       Date:  2022-01-26       Impact factor: 5.854

Review 6.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

7.  MiR-379-5p Promotes Chondrocyte Proliferation via Inhibition of PI3K/Akt Pathway by Targeting YBX1 in Osteoarthritis.

Authors:  Hongjun Zhang; Wendi Zheng; Du Li; Jia Zheng
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

8.  Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.

Authors:  Yufeng Wang; Zhikui Liu; Bowen Yao; Qing Li; Liang Wang; Cong Wang; Changwei Dou; Meng Xu; Qingguang Liu; Kangsheng Tu
Journal:  Mol Cancer       Date:  2017-07-17       Impact factor: 27.401

9.  Neurofibromin Deficiency and Extracellular Matrix Cooperate to Increase Transforming Potential through FAK-Dependent Signaling.

Authors:  Andrea Errico; Anna Stocco; Vincent M Riccardi; Alberto Gambalunga; Franco Bassetto; Martina Grigatti; Amedeo Ferlosio; Gianluca Tadini; Debora Garozzo; Stefano Ferraresi; Andrea Trevisan; Sandra Giustini; Andrea Rasola; Federica Chiara
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

10.  Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway.

Authors:  Xiaohui Zhao; Dayu Zhou; Yunen Liu; Chun Li; Xiaoguang Zhao; Ying Li; Wei Li
Journal:  Mol Med Rep       Date:  2017-10-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.